vs

Side-by-side financial comparison of Clarus Corp (CLAR) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Clarus Corp is the larger business by last-quarter revenue ($65.4M vs $37.2M, roughly 1.8× Organogenesis Holdings Inc.). On growth, Clarus Corp posted the faster year-over-year revenue change (-8.4% vs -57.1%). Over the past eight quarters, Clarus Corp's revenue compounded faster (-2.9% CAGR vs -46.5%).

Clarus Corp is a global designer, manufacturer, and distributor of high-performance outdoor recreation, climbing, camping, and lifestyle products. It manages a portfolio of leading consumer brands, serving outdoor enthusiasts, professional athletes, and retail partners across North America, Europe, and the Asia-Pacific region, with a focus on innovative, durable gear for active lifestyles.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

CLAR vs ORGO — Head-to-Head

Bigger by revenue
CLAR
CLAR
1.8× larger
CLAR
$65.4M
$37.2M
ORGO
Growing faster (revenue YoY)
CLAR
CLAR
+48.7% gap
CLAR
-8.4%
-57.1%
ORGO
Faster 2-yr revenue CAGR
CLAR
CLAR
Annualised
CLAR
-2.9%
-46.5%
ORGO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CLAR
CLAR
ORGO
ORGO
Revenue
$65.4M
$37.2M
Net Profit
$-31.3M
Gross Margin
27.7%
30.8%
Operating Margin
-59.6%
-185.1%
Net Margin
-47.8%
Revenue YoY
-8.4%
-57.1%
Net Profit YoY
52.3%
EPS (diluted)
$-0.81

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLAR
CLAR
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$65.4M
$225.6M
Q3 25
$69.3M
$150.9M
Q2 25
$55.2M
$101.0M
Q1 25
$60.4M
$86.7M
Q4 24
$71.4M
$126.7M
Q3 24
$67.1M
$115.2M
Q2 24
$56.5M
$130.2M
Net Profit
CLAR
CLAR
ORGO
ORGO
Q1 26
Q4 25
$-31.3M
$43.7M
Q3 25
$-1.6M
$21.6M
Q2 25
$-8.4M
$-9.4M
Q1 25
$-5.2M
$-18.8M
Q4 24
$-65.5M
$7.7M
Q3 24
$-3.2M
$12.3M
Q2 24
$-5.5M
$-17.0M
Gross Margin
CLAR
CLAR
ORGO
ORGO
Q1 26
30.8%
Q4 25
27.7%
Q3 25
35.1%
Q2 25
35.6%
Q1 25
34.4%
72.6%
Q4 24
33.4%
75.5%
Q3 24
35.0%
76.7%
Q2 24
36.1%
77.6%
Operating Margin
CLAR
CLAR
ORGO
ORGO
Q1 26
-185.1%
Q4 25
-59.6%
28.1%
Q3 25
-4.4%
13.7%
Q2 25
-19.7%
-12.5%
Q1 25
-11.2%
-30.9%
Q4 24
-70.2%
8.1%
Q3 24
-8.0%
5.4%
Q2 24
-14.4%
-10.7%
Net Margin
CLAR
CLAR
ORGO
ORGO
Q1 26
Q4 25
-47.8%
19.4%
Q3 25
-2.3%
14.3%
Q2 25
-15.3%
-9.3%
Q1 25
-8.7%
-21.7%
Q4 24
-91.8%
6.1%
Q3 24
-4.7%
10.7%
Q2 24
-9.7%
-13.1%
EPS (diluted)
CLAR
CLAR
ORGO
ORGO
Q1 26
Q4 25
$-0.81
$0.31
Q3 25
$-0.04
$0.11
Q2 25
$-0.22
$-0.10
Q1 25
$-0.14
$-0.17
Q4 24
$-1.72
$0.05
Q3 24
$-0.08
$0.09
Q2 24
$-0.14
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLAR
CLAR
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$36.7M
$91.4M
Total DebtLower is stronger
$0
Stockholders' EquityBook value
$196.4M
Total Assets
$249.0M
$520.0M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLAR
CLAR
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$36.7M
$93.7M
Q3 25
$29.5M
$63.7M
Q2 25
$28.5M
$73.1M
Q1 25
$41.3M
$110.0M
Q4 24
$45.4M
$135.6M
Q3 24
$36.4M
$94.3M
Q2 24
$46.2M
$89.9M
Total Debt
CLAR
CLAR
ORGO
ORGO
Q1 26
Q4 25
$0
Q3 25
$2.0M
Q2 25
$1.9M
Q1 25
$1.9M
Q4 24
$1.9M
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
CLAR
CLAR
ORGO
ORGO
Q1 26
Q4 25
$196.4M
$300.1M
Q3 25
$225.8M
$255.1M
Q2 25
$225.1M
$233.2M
Q1 25
$229.3M
$242.9M
Q4 24
$233.1M
$262.9M
Q3 24
$308.5M
$278.5M
Q2 24
$307.3M
$263.5M
Total Assets
CLAR
CLAR
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$249.0M
$598.7M
Q3 25
$283.1M
$509.8M
Q2 25
$286.5M
$461.1M
Q1 25
$292.8M
$467.4M
Q4 24
$294.1M
$497.9M
Q3 24
$375.3M
$446.3M
Q2 24
$369.4M
$443.2M
Debt / Equity
CLAR
CLAR
ORGO
ORGO
Q1 26
Q4 25
0.00×
Q3 25
0.01×
Q2 25
0.01×
Q1 25
0.01×
Q4 24
0.01×
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLAR
CLAR
ORGO
ORGO
Operating Cash FlowLast quarter
$12.5M
Free Cash FlowOCF − Capex
$11.6M
FCF MarginFCF / Revenue
17.7%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-9.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLAR
CLAR
ORGO
ORGO
Q1 26
Q4 25
$12.5M
$39.4M
Q3 25
$-5.7M
$3.1M
Q2 25
$-9.4M
$-32.9M
Q1 25
$-2.1M
$-19.9M
Q4 24
$16.6M
$10.9M
Q3 24
$-8.3M
$8.7M
Q2 24
$834.0K
$4.7M
Free Cash Flow
CLAR
CLAR
ORGO
ORGO
Q1 26
Q4 25
$11.6M
$34.8M
Q3 25
$-7.0M
$844.0K
Q2 25
$-11.3M
$-36.5M
Q1 25
$-3.3M
$-23.6M
Q4 24
$14.4M
$7.6M
Q3 24
$-9.4M
$6.1M
Q2 24
$-744.0K
$2.9M
FCF Margin
CLAR
CLAR
ORGO
ORGO
Q1 26
Q4 25
17.7%
15.4%
Q3 25
-10.0%
0.6%
Q2 25
-20.4%
-36.1%
Q1 25
-5.4%
-27.2%
Q4 24
20.1%
6.0%
Q3 24
-14.0%
5.3%
Q2 24
-1.3%
2.2%
Capex Intensity
CLAR
CLAR
ORGO
ORGO
Q1 26
Q4 25
1.4%
2.1%
Q3 25
1.8%
1.5%
Q2 25
3.4%
3.6%
Q1 25
2.0%
4.2%
Q4 24
3.1%
2.7%
Q3 24
1.6%
2.2%
Q2 24
2.8%
1.4%
Cash Conversion
CLAR
CLAR
ORGO
ORGO
Q1 26
Q4 25
0.90×
Q3 25
0.14×
Q2 25
Q1 25
Q4 24
1.43×
Q3 24
0.71×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLAR
CLAR

Other$37.1M57%
Outdoor Segment$25.3M39%
Adventure Segment$3.0M5%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons